Bernardo Perin Cima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bernardo Perin Cima has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Juliana Dal Ri Lindenau
Universidade Federal de Santa Catarina, Brazil
3 shared publications - Yara Costa Netto Muniz
Department of Cell Biology, Embryology, and Genetics, Center for Biological Sciences, Federal University of SantaCatarina, Florianópolis, Brazil
2 shared publications - Alexandre Holzbach Júnior
Federal University of Santa Catarina/Center for Health Sciences
1 shared publication - Andre Akira Gonzaga Yoshikawa
Laboratório de Transporte e Logística (LabTrans) Universidade Federal de Santa Catarina Florianópolis SC Brazil
1 shared publication - Carmen Elena Barragán-Ruiz
Laboratório de Genética e Biodiversidade (LGBio) Universidade Federal de Goiás Goiânia GO Brazil
1 shared publication - Dalmo Almeida de Azevedo
Laboratório DNA Forense, Instituto de Ciências Biológicas e da Saúde Universidade Federal de Alagoas Maceió AL Brazil
1 shared publication
Latest Publications
- Open Access
- 19 June 2026
- Published by Wiley in The Journal of Wildlife Management
- Vol. 90 (6) , e70226
DNA barcoding for identification of species involved in wildlife strikes at Brazilian airports
This study evaluated the effectiveness of DNA barcoding for identifying species involved in wildlife–aircraft collisions that could not be morphologically identified. Samples were collected at 42 Brazilian civil airports and analyzed in 3 public laboratories using Cytochrome c oxidase I (COI) sequencing. Between 3 April 2023 and 20 February 2026, we analyzed 520 DNA samples, of which 370 (71%) were successfully identified to the species or genus level—encompassing 4 animal classes, 24 orders, and 80 species. Birds accounted for 77% of identified collisions, while bats represented 20%. The most frequently identified species were the southern lapwing ( Vanellus chilensis ), the eared dove ( Zenaida auriculata ), and the velvety free‐tailed bat ( Molossus molossus ). Among the 80 distinct species identified, 17 bird species and 15 bat species had not been previously reported in Brazil's wildlife strike records. Rarefaction analysis showed a continuous increase in species richness without reaching an asymptote, indicating that additional sampling may reveal more species involved in wildlife strikes. We did not detect differences in species composition among biomes, although we found strong evidence of within‐biome variability. Temporally, strike frequency varied markedly by month but showed no consistent seasonal pattern. Species identification success was comparable to previous large‐scale studies (χ 2 = 1.62, P = 0.45; Cramér's V = 0.03), indicating no substantial methodological effect on identification rates. These findings demonstrate the operational effectiveness of DNA barcoding for wildlife strike identification and provide valuable data to enhance wildlife strike records in Brazil.
- 19 June 2026
- Published by Wiley in The Journal of Wildlife Management
- Vol. 90 (6) , e70226
Open AccessDNA barcoding for identification of species involved in wildlife strikes at Brazilian airports
This study evaluated the effectiveness of DNA barcoding for identifying species involved in wildlife–aircraft collisions that could not be morphologically identified. Samples were collected at 42 Brazilian civil airports and analyzed in 3 public laboratories using Cytochrome c oxidase I (COI) sequencing. Between 3 April 2023 and 20 February 2026, we analyzed 520 DNA samples, of which 370 (71%) were successfully identified to the species or genus level—encompassing 4 animal classes, 24 orders, and 80 species. Birds accounted for 77% of identified collisions, while bats represented 20%. The most frequently identified species were the southern lapwing ( Vanellus chilensis ), the eared dove ( Zenaida auriculata ), and the velvety free‐tailed bat ( Molossus molossus ). Among the 80 distinct species identified, 17 bird species and 15 bat species had not been previously reported in Brazil's wildlife strike records. Rarefaction analysis showed a continuous increase in species richness without reaching an asymptote, indicating that additional sampling may reveal more species involved in wildlife strikes. We did not detect differences in species composition among biomes, although we found strong evidence of within‐biome variability. Temporally, strike frequency varied markedly by month but showed no consistent seasonal pattern. Species identification success was comparable to previous large‐scale studies (χ 2 = 1.62, P = 0.45; Cramér's V = 0.03), indicating no substantial methodological effect on identification rates. These findings demonstrate the operational effectiveness of DNA barcoding for wildlife strike identification and provide valuable data to enhance wildlife strike records in Brazil.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 49 (suppl 1) , e20250216
Influence of reward-related genetic variants on BMI and predisposition to obesity: Systematic review and meta-analysis
Obesity results from a chronic imbalance between caloric intake and energy expenditure, leading to the accumulation of excess body fat. This imbalance is influenced by endocrine, molecular, genetic, demographic, environmental, and lifestyle factors, with the brain reward cascade emerging as a key overlapping pathway. This study hypothesizes that cascade dysregulation leads to reward deficiency, causing stronger cravings and overeating. This study investigates the contribution of genetic variants in the brain reward cascade to body mass index (BMI), overweight, and obesity. A systematic search was conducted across five databases. Eligible studies evaluated associations between variants in reward-related genes (COMT, DRD2, DRD4, MAO-A, SLC6A3, SLC6A4) and BMI or obesity. In total, 117 studies were included in the systematic review, and 31 provided sufficient data for meta-analysis. Eighteen variants showed significant associations with BMI, with the strongest evidence observed for the Val158Met (COMT), Taq1A (DRD2), 48 bp VNTR (DRD4), 40 bp VNTR (SLC6A3) and 5-HTTLPR (SLC6A4). Meta-analyses of Taq1A showed a significant association of the A1 allele with obesity. This study highlights consistent associations between genetic variants in the reward cascade and susceptibility to weight gain, providing a foundation for more precise prevention and personalized obesity management.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Genetics and Molecular Biology
- Vol. 49 (suppl 1) , e20250216
Open AccessInfluence of reward-related genetic variants on BMI and predisposition to obesity: Systematic review and meta-analysis
Obesity results from a chronic imbalance between caloric intake and energy expenditure, leading to the accumulation of excess body fat. This imbalance is influenced by endocrine, molecular, genetic, demographic, environmental, and lifestyle factors, with the brain reward cascade emerging as a key overlapping pathway. This study hypothesizes that cascade dysregulation leads to reward deficiency, causing stronger cravings and overeating. This study investigates the contribution of genetic variants in the brain reward cascade to body mass index (BMI), overweight, and obesity. A systematic search was conducted across five databases. Eligible studies evaluated associations between variants in reward-related genes (COMT, DRD2, DRD4, MAO-A, SLC6A3, SLC6A4) and BMI or obesity. In total, 117 studies were included in the systematic review, and 31 provided sufficient data for meta-analysis. Eighteen variants showed significant associations with BMI, with the strongest evidence observed for the Val158Met (COMT), Taq1A (DRD2), 48 bp VNTR (DRD4), 40 bp VNTR (SLC6A3) and 5-HTTLPR (SLC6A4). Meta-analyses of Taq1A showed a significant association of the A1 allele with obesity. This study highlights consistent associations between genetic variants in the reward cascade and susceptibility to weight gain, providing a foundation for more precise prevention and personalized obesity management.
- 1 June 2023
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 23 (11) , 1222-1236
A Review and Meta-analysis on Trastuzumab Resistance in Patients with HER2+ Breast Cancer
Background: Trastuzumab is a monoclonal antibody that revolutionized the treatment of HER2+ breast cancer. However, about 30% of patients demonstrate resistance to this drug Objective: The purpose of this study is to identify the mechanisms involved in resistance to treatment with trastuzumab in women undergoing HER2+ breast cancer treatment. Methods: A wide review and meta-analysis were performed in the PubMed and Scielo databases up to January 2022. All articles that analyzed the efficacy of the drug in HER2+ human patients treated with trastuzumab were selected, except reviews, meta-analyses, and reports. Egger’s test was applied to verify publication bias. Forest plot and PRISMA flowchart were employed. Results: 60 articles were selected for the review and 15 included in the meta-analysis. A total of 102 resistance mechanisms were identified, 73 of which are different from each other. The mechanisms have been classified into 5 different categories. The main resistance mechanisms found are in the PI3K/Akt/mTOR pathway or related to low HER2, often resulting from failure to assess HER2 status. Both groups presented statistical significance. The two groups were not significantly different from each other. Conclusion: Drug resistance is the main challenge of trastuzumab-based treatment. To overcome this challenge, it is important to continue efforts to understand the mechanisms of cancer drug resistance, identify therapies that can treat refractory cancer to current therapies, and possibly create a panel of genes that predict resistance, avoiding symptomatic and economic costs. The main limitation of this study was the selection and population bias. PROSPERO Registration Number: This study is registered in PROSPERO (CRD42020169304).
- 1 June 2023
- Published by Bentham Science Publishers Ltd. in Mini-Reviews in Medicinal Chemistry
- Vol. 23 (11) , 1222-1236
A Review and Meta-analysis on Trastuzumab Resistance in Patients with HER2+ Breast Cancer
Background: Trastuzumab is a monoclonal antibody that revolutionized the treatment of HER2+ breast cancer. However, about 30% of patients demonstrate resistance to this drug Objective: The purpose of this study is to identify the mechanisms involved in resistance to treatment with trastuzumab in women undergoing HER2+ breast cancer treatment. Methods: A wide review and meta-analysis were performed in the PubMed and Scielo databases up to January 2022. All articles that analyzed the efficacy of the drug in HER2+ human patients treated with trastuzumab were selected, except reviews, meta-analyses, and reports. Egger’s test was applied to verify publication bias. Forest plot and PRISMA flowchart were employed. Results: 60 articles were selected for the review and 15 included in the meta-analysis. A total of 102 resistance mechanisms were identified, 73 of which are different from each other. The mechanisms have been classified into 5 different categories. The main resistance mechanisms found are in the PI3K/Akt/mTOR pathway or related to low HER2, often resulting from failure to assess HER2 status. Both groups presented statistical significance. The two groups were not significantly different from each other. Conclusion: Drug resistance is the main challenge of trastuzumab-based treatment. To overcome this challenge, it is important to continue efforts to understand the mechanisms of cancer drug resistance, identify therapies that can treat refractory cancer to current therapies, and possibly create a panel of genes that predict resistance, avoiding symptomatic and economic costs. The main limitation of this study was the selection and population bias. PROSPERO Registration Number: This study is registered in PROSPERO (CRD42020169304).
- Open Access
- 13 September 2022
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 68 (4)
Quanto você Sabe sobre Câncer de Mama? Avaliação do Nível de Conhecimento da População Brasileira
Introdução: Apesar dos esforços de conscientização da população, permanecem altas a incidência e a mortalidade decorrente de câncer de mama em mulheres brasileiras. Objetivo: Avaliar o nível de conhecimento da população brasileira sobre os fatores de risco que levam ao desenvolvimento dessa doença. Método: Foi utilizado um questionário estruturado on-line, enviado de setembro a dezembro de 2021, por meio das redes sociais e e-mail. Os participantes foram divididos em subgrupos (escolaridade, área de formação profissional, gênero, contato com indivíduos afetados pela doença e faixas de idade), e o teste de qui-quadrado foi realizado para verificar diferenças significativas entre eles. Resultados: Analisando as 200 respostas válidas da amostra como um todo, a taxa de acertos foi alta, ficando acima dos 70%. Ao contrapor os subgrupos, foram identificados resultados significativos para as análises relativas a escolaridade (p=0,016), área de formação (p=0,004), gênero (p=0,045) e proximidade com a doença (p=0,004), em que foi observado que as menores taxas de acertos foram de pessoas com o nível de escolaridade mais baixa, que não fazem parte da área de saúde, do sexo masculino e que não tiveram contato com pessoas próximas portadoras da doença. Conclusão: Foi possível avaliar o conhecimento dos participantes sobre o tema, entretanto, as ações atuais tomadas por grupos de extensão e divulgação científica e instituições de combate ao câncer de mama são válidas para alguns subgrupos, mas precisam atingir com mais qualidade pessoas de menor escolaridade, pessoas que não possuem formação na área da saúde e pessoas do sexo masculino.
- 13 September 2022
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 68 (4)
Open AccessQuanto você Sabe sobre Câncer de Mama? Avaliação do Nível de Conhecimento da População Brasileira
Introdução: Apesar dos esforços de conscientização da população, permanecem altas a incidência e a mortalidade decorrente de câncer de mama em mulheres brasileiras. Objetivo: Avaliar o nível de conhecimento da população brasileira sobre os fatores de risco que levam ao desenvolvimento dessa doença. Método: Foi utilizado um questionário estruturado on-line, enviado de setembro a dezembro de 2021, por meio das redes sociais e e-mail. Os participantes foram divididos em subgrupos (escolaridade, área de formação profissional, gênero, contato com indivíduos afetados pela doença e faixas de idade), e o teste de qui-quadrado foi realizado para verificar diferenças significativas entre eles. Resultados: Analisando as 200 respostas válidas da amostra como um todo, a taxa de acertos foi alta, ficando acima dos 70%. Ao contrapor os subgrupos, foram identificados resultados significativos para as análises relativas a escolaridade (p=0,016), área de formação (p=0,004), gênero (p=0,045) e proximidade com a doença (p=0,004), em que foi observado que as menores taxas de acertos foram de pessoas com o nível de escolaridade mais baixa, que não fazem parte da área de saúde, do sexo masculino e que não tiveram contato com pessoas próximas portadoras da doença. Conclusão: Foi possível avaliar o conhecimento dos participantes sobre o tema, entretanto, as ações atuais tomadas por grupos de extensão e divulgação científica e instituições de combate ao câncer de mama são válidas para alguns subgrupos, mas precisam atingir com mais qualidade pessoas de menor escolaridade, pessoas que não possuem formação na área da saúde e pessoas do sexo masculino.